跳至主要内容
临床试验/NCT06585072
NCT06585072招募中不适用

Prospective Cohort Study on Endo-Exdo Secretory Function Alterations and All-round Outcomes After Pancreatic Cancer

Shanghai Changzheng Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Number of Participants Who developed glucose metabolic disorders(pre-diabetes and diabetes mellitus)

研究概览

简要总结

The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are:

  1. Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same?
  2. Are alterations in endocrine and exdocrine secretory function in patients with pancreatic surgery associated with all-round outcomes? All patients with pancreatic surgery have been given the standardized treatment for the condition.

The reasearchers will summarize the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) during different surgical procedures to explore the association between alternations in endocrine and exdocrine secrectory function and all-round outcomes.

详细描述

Investigators will prospectively collect data from patients with pancreatic cancer after surgery in participant centers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female Chinese subjects;
  • Age ≥ 18 years;
  • patients with pancreatic cancer who are proposed to undergo pancreatectomy by pancreaticobiliary surgery at our hospital;
  • those who voluntarily completed the Pancreatobiliary Surgery Cohort Study and signed the informed consent;
  • those who have completed and banked serum and pathological specimens at our hospital.

排除标准

  • those with a previous history of comorbid diabetes mellitus or pre-diabetes mellitus, or preoperative HbA1C ≥ 6.0% or fasting blood glucose ≥ 6.1 mmol/l;
  • those with positive islet-associated antibodies
  • those with the presence of medications, endocrine disease exposures that can lead to a risk of secondary diabetes;
  • pregnant or nursing women;
  • Cognitive impairment or other reasons for failing to sign the informed consent form.

结局指标

主要结局

Number of Participants Who developed glucose metabolic disorders(pre-diabetes and diabetes mellitus)

时间窗: From enrollment to five years after the end of the surgery

The diagnosis of glucose disorders should be made applying criteria of the American Diabetes Association.

次要结局

  • Overall Survival(From enrollment to five years after the end of the surgery)
  • Disease-Free Survival(From enrollment to five years after the end of the surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

LiTuo

Deputy Director

Shanghai Changzheng Hospital

研究点 (1)

Loading locations...

相似试验

Pancreatic Cancer and Diabetes Mellitus | 临床试验